ArticleInnovation in aging2025
Fidelity matters: implementing ADS Plus, an evidence-based program, in multiple adult day service sites.
Article in Innovation in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02927821 (Improving Outcome for Family Caregivers of Older Adults With Complex Conditions), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Improving Outcome for Family Caregivers of Older Adults With Complex Conditions: The Adult Day Plus (ADS Plus) Program
Who cites it
3 citing papers in PubMed.
- Impact of the Tailored Activity Program (TAP) on Depressive Symptoms Among White and Black Dementia Caregivers.Journal of the American Geriatrics Society · 2025Trial
- Adult day services, leisure time satisfaction, and psychosocial well-being among dementia caregivers.The Gerontologist · 2026Article
- Toward a payment model for augmenting Adult Day Services (ADS) with caregiver support: costs, willingness, and ability to pay for the ADS Plus program.Innovation in aging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background and Objectives: In a cluster randomized trial, we found that augmenting adult day services (ADS) with a multicomponent caregiver support program, ADS Plus, reduced caregiver depressive symptoms and increased ADS use. Unclear is whether the program was implemented with fidelity across sites and the relationship of fidelity to site characteristics and caregiver outcomes. Research Design and Methods: Sixteen ADS sites were randomly assigned to ADS Plus ( Results: Of 102 caregivers, 79.5% were in high ( Discussion and Implications: Most caregivers received ADS Plus with moderate to high fidelity. High/moderate fidelity sites delivered more sessions to more caregivers with substantially stronger caregiver benefits. As fidelity varied by site characteristics, adaptations to staff training and the program appear needed for low-fidelity sites. Clinical Trial Registration Number: NCT02927821.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.